Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 2 Nov 20 424B3 Prospectus supplement
- 30 Oct 20 EFFECT Notice of effectiveness
- 28 Oct 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 21 Oct 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 15 Oct 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 30 Sep 20 S-4/A Registration of securities issued in business combination transactions (amended)
-
24 Jul 20 S-4 Registration of securities issued in business combination transactions
PTPI similar filings
- 21 Oct 20 Registration of securities issued in business combination transactions (amended)
- 15 Oct 20 Registration of securities issued in business combination transactions (amended)
- 30 Sep 20 Registration of securities issued in business combination transactions (amended)
- 24 Jul 20 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 99.5
Consent to be Named as a Director
In connection with the filing by Petros Pharmaceuticals, Inc. of the Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named to the board of directors of Petros Pharmaceuticals, Inc., and any successor thereto, as described in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
Dated: July 20, 2020
/s/ John D. Shulman | |
John D. Shulman |